| Prevalence of Pre-antiretroviral-Treatment Drug Resistance by Gender, Age, and Other Factors in HIV-Infected Individuals Initiating Therapy in Kenya, 2013–2014 RA Silverman, IA Beck, C Kiptinness, M Levine, R Milne, CJ McGrath, ... The Journal of infectious diseases 216 (12), 1569-1578, 2017 | 37 | 2017 |
| Minority and majority pre-treatment HIV-1 drug resistance associated with failure of 1st-line NNRTI Art in Kenyan women RS Milne, RA Silverman, IA Beck, J Mckernan-Mullin, W Deng, TR Sibley, ... AIDS (London, England), 2019 | 27* | 2019 |
| Persistence of HIV drug resistance among South African children given nevirapine to prevent mother-to-child-transmission R Kanthula, TM Rossouw, UD Feucht, G Van Dyk, IA Beck, R Silverman, ... AIDS (London, England) 31 (8), 1143, 2017 | 24 | 2017 |
| Predictors of mortality within the first year of initiating antiretroviral therapy in urban and rural Kenya: A prospective cohort study RA Silverman, GC John-Stewart, IA Beck, R Milne, C Kiptinness, ... PloS one 14 (10), e0223411, 2019 | 23 | 2019 |
| Increasing HIV-1 pre-treatment drug resistance among antiretroviral-naive adults initiating treatment between 2006 and 2014 in Nairobi, Kenya MH Chung, R Silverman, IA Beck, N Yatich, S Dross, J McKernan-Mullin, ... AIDS (London, England) 30 (10), 1680, 2016 | 21 | 2016 |
| Sexually Transmitted Disease Partner Services Costs, Other Resources, and Strategies Across Jurisdictions to Address Unique Epidemic Characteristics and Increased Incidence RA Silverman, DA Katz, C Levin, TR Bell, D Spellman, LS John, ... Sexually transmitted diseases 46 (8), 493-501, 2019 | 10 | 2019 |
| Vaccine Effectiveness during Outbreak of COVID-19 Alpha (B. 1.1. 7) Variant in Men’s Correctional Facility, United States RA Silverman, A Ceci, A Cohen, M Helmick, E Short, P Bordwine, ... Emerging Infectious Diseases 28 (7), 1321, 2022 | 9 | 2022 |
| Prospective randomized HIV drug resistance testing of Kenyans before 1 st-line ART MH Chung, IA Beck, M Levine, C Kiptiness, J Munyao, R Silverman, ... | 3 | 2016 |
| P3.130 potential impact of testing for : a mathematical modelling analysismycoplasma genitalium: a mathematical modelling analysis infection and macrolide … LC Chambers, LE Manhart, RA Silverman, RV Barnabas Sexually Transmitted Infections 93 (Suppl_2), A141-A142, 2017 | 1* | 2017 |
| COVID-19 related messaging, beliefs, information sources, and mitigation behaviors in Virginia: A cross-sectional survey in the summer of 2020 RA Silverman, D Short, S Wenzel, MA Friesen, NE Cook PeerJ 12, e16714, 2024 | | 2024 |
| A mixed methods investigation of how young adults in Virginia received, evaluated, and responded to COVID-19 public health messaging NE Cook, S Wenzel, RA Silverman, D Short, KA Jiles, T Markwalter, ... | | 2022 |
| Violence-related behaviors and prevention strategies: 12 year trends among roanoke county, Virginia 7-12th grade students K Redican, D Sallee, N Hans, R Silverman APHA's 2020 VIRTUAL Annual Meeting and Expo (Oct. 24-28), 2020 | | 2020 |
| O19. 3 Partner services for gonorrhea can decrease new HIV among MSM in king county, washington: a mathematical modeling study G Liu, C Broshkevitch, D Katz, R Silverman, M Golden, R Barnabas Sexually Transmitted Infections 95 (Suppl 1), A83, 2019 | | 2019 |
| Informing Strategies for Effective HIV Treatment and Prevention RA Silverman | | 2018 |
| Persistence of HIV Drug Resistance Among South African Children Exposed to Nevirapine Prophylaxis for Prevention of Mother-to-Child-Transmission (pMTCT) R Kanthula, I Beck, GV Dyk, R Silverman, S Olson, C Salyer, S Cassol, ... Open Forum Infectious Diseases 2 (suppl_1), 466, 2015 | | 2015 |
| Mortality Across Two ART Trials Enrolling at≤ 200 vs≤ 350 CD4 cells/uL in Kenya RA Silverman, M Chung, JN Kiarie, N Yatich, J Njoroge, C Kiptiness, ... | | 2015 |
| Population-Level Effectiveness and Cost-Effectiveness of Enhanced Partner Services for Curable Sexually Transmitted Infections: A Systematic Review ST Roberts, DA Katz, MR Golden, RA Silverman, TR Bell, RV Barnabas | | |
